Amgen Inc. vs Pfizer, Inc. — Stock Comparison
Amgen Inc. (AMGN) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Amgen Inc. narrowly edges Pfizer, Inc. on Q·Score (6.7 vs 6.2 out of 10), led by Quality (9.3 vs 6.4) and Growth (6.3 vs 5.1). Pfizer, Inc. scores higher on Health, reflecting stronger balance sheet strength. Analyst consensus targets imply greater upside for PFE (+12.3%) than for AMGN (+0.6%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 101% return on equity and 21% profit margins.
⚠ high leverage at 6.2× debt-to-equity.
Consistently beats earnings estimates (4/4 quarters).
⚠ earnings contracting 10% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
AMGN vs PFE: which stock scores better overall?
Based on Q·Score, Amgen Inc. (AMGN) scores 6.7/10 versus Pfizer, Inc. (PFE) at 6.2/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: AMGN or PFE?
Amgen Inc. (AMGN) scores higher on Growth (6.3/10 vs 5.1/10). Amgen Inc. reports revenue growth (5.8% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is AMGN or PFE more attractively valued?
Pfizer, Inc. (PFE) scores higher on Valuation (7/10 vs 6.8/10). AMGN trades at 14.9× P/E versus PFE at 9.2×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about AMGN vs PFE?
There are 30 analysts covering AMGN with a consensus price target of $352.50, and 27 analysts covering PFE with a consensus target of $29.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: AMGN or PFE?
Amgen Inc. (AMGN) scores higher on Quality (9.3/10 vs 6.4/10). Net profit margin: AMGN at 21.0%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: AMGN or PFE?
Pfizer, Inc. (PFE) scores higher on Financial Health (7/10 vs 4.5/10). Market beta: AMGN at 0.42, PFE at 0.29. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of AMGN and PFE?
Amgen Inc. (AMGN) has a market capitalisation of $189.2B, while Pfizer, Inc. (PFE) has a market cap of $148.2B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do AMGN or PFE pay dividends?
AMGN pays a dividend yield of 2.88%, while PFE pays a dividend yield of 6.62%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →